Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars.
Big Pharma bets on AI to speed up clinical trials
The timeline for life-saving drugs being made available to the public depends in large part on how quickly clinical trials can be conducted. Here's how AI is changing the game.
